SFNano organises seminars, workshops and discussions in order to favor a French network, and broader, in collaboration with European nanomedicine societies. SFNano gathers academics from CNRS, INSERM, Universities, CEA as well as non-academics.
The ETP Nanomedicine is an initiative led by industry and set up together with the European Commission, which is addressing the application of nanotechnology to achieve breakthroughs in healthcare.
The European Foundation for Clinical Nanomedicine is a non-profit institution aiming at advancing medicine to the benefit of individuals and society through the application of nanoscience.
European Network of Excellence in nanobiotechnologyNano2Life.
The NanomedTV is an online TV dedicated to nanomedicine, created by Nanobiotix and the European Technology Platform of Nanomedicine.
The NMP NCP Network is the main provider of guidance, practical information and individual assistance of participation in the thematic priority “Nanocscience, nanotechnologies, materials & new production technologies (NMP)” of the Seventh Framework Programme (FP7).NMP NCP Network.
The EU NanoSafety Cluster is an initiative to maximise the synergies between the existing FP6 and FP7 projects addressing all aspects of nanosafety including toxicology, ecotoxicology, exposure assessment, mechanisms of interaction, risk assessment and standardisation
An overview of European efforts in Nanomedicine.
The Nanomed 2020 project “Enabling the European Nanomedicine Area until 2020” is starting on 1st September 2012.
EuroNanoMed III is funded under the ERA-NET Cofund scheme of the Horizon 2020 Research and Innovation Framework Programme of the European Commission, Research Directorate-General, Grant Agreement No. 723770
Instituto de Salud Carlos III (ISCIII)
Monforte de Lemos 5, 28029 – Madrid, Spain
era@isciii.esCoordinator
Ignacio Baananteibaanante@isciii.es
+34 9182 22576Instituto de Salud Carlos III (ISCIII)
Monforte de Lemos 5, 28029 – Madrid, Spainma.valencia@isciii.es+ 34 91 822 2227VDI Technologiezentrum GmbH
Dr. Olaf Rotthausrotthaus@vdi.de+49 211 6214 233Ⓒ All rights reserved EuroNanoMed III, 2018
